Psoriasis

An Expert Global Perspective

Häftad, Engelska, 2027

2 229 kr

Kommande

Offering a solid foundation of current knowledge on psoriasis as well as an up-to-date discussion of recent advancements in treatment research and new drug approvals, Psoriasis: An Expert Global Perspective is a one-stop reference for clinicians, researchers, and policy makers who seek a definitive, comprehensive resource in this fast-moving field. Developed in collaboration with and supported by the International Psoriasis Council, whose members are leading clinicians and researchers specializing in psoriasis, this first-of-its-kind text offers unparalleled global expertise on this chronic inflammatory disease. Readers will develop a thorough understanding of psoriasis’s complex clinical presentations, subtypes, and associated comorbidities-exactly the knowledge needed to help patients make informed choices about their treatments so they can live longer, healthier lives free of the burden of psoriatic disease.

Produktinformation

Utgivningsdatum2027-03-29
Mått216 x 276 x undefined mm
FormatHäftad
SpråkEngelska
Antal sidor368
FörlagElsevier Health Sciences
ISBN9780443434235

Tillhör följande kategorier

Dermatologi inom Medicin

Dr. Joel M. Gelfand is the James J. Leyden Endowed Professor of Clinical Investigation and Professor of Dermatology and Epidemiology at the University of Pennsylvania Perelman School of Medicine. As co-founder and Director of the Center for Clinical Sciences in Dermatology and the Psoriasis and Phototherapy Treatment Center, Dr. Gelfand is a leading expert in psoriasis, epidemiology, drug safety, and clinical trials. His pioneering research first identified the increased risk of cardiovascular disease and mortality in psoriasis patients, influencing clinical practice worldwide.With over 330 scientific publications and an H-index of 101, Dr. Gelfand's work has been widely recognized and cited across top medical journals. He founded the Dermatology Clinical Effectiveness Research Network (DCERN), fostering patient-centered research across the United States. Recipient of numerous prestigious awards, Dr. Gelfand is also Deputy Editor for Clinical Research at the Journal of Investigative Dermatology and Chief Medical Editor for Healio Dermatology.

Section 1: Overview of Psoriasis: History, epidemiology, and Immunogentic Etiology1. Historical considerations about psoriasis2. Global epidemiology and burden of psoriasis3. Genetics of psoriasis4. Pathophysiology of psoriasisSection 2: Clinical Evaluation of Psoriasis5. Clinical Presentation and Assessment of Psoriasis and High Impact Sites6. Subtypes of Psoriasis (Erythrodermic, Guttate and Pustular Psoriasis)7. Nails8. Assessing health related quality of life in psoriasisSection 3: Treatment of Psoriasis and its Subtypes9. Vehicles for Topical Therapy10. Topical medications11. Ultraviolet approaches12. Old Oral Remedies for Psoriasis13. Traditional Medications including Methotrexate, Retinoids, and Cyclosporine14. Newer Oral Medications (apremilast, Deucravacitinib and other JAKi)15. Biologics (including biosimilars)16. Lifestyle Management (Herbs, Acupuncture, etc)Section 4: Special Populations17. Special Populations and Psoriasis: Pediatric Patients18. Special Populations and Psoriasis: Women19. Special Populations and Psoriasis: Older AdultsSection 5: Comorbidity20. Psoriatic arthritis21. Obesity and Insulin Resistance22. Psoriasis and cardiovascular disease23. Psoriasis and Psychiatric Comorbidity24. Gastrointestinal Comorbidities in Psoriasis (Excluding Hepatic Disease): IBD and Non-IBD Conditions25. Hepatic and Renal Comorbidities in Psoriasis26. Psoriasis and MalignancySection 6: The Future27. Investigational Treatments for Psoriasis28. Artificial Intelligence in Psoriasis29. Teledermatology30. Role of Patient Advocacy and Contemporary Portrayal of Psoriasis in the Media